Effectiveness and safety of tofacitinib in rheumatoid arthritis: a cohort study

BACKGROUND: Tofacitinib is the first oral Janus kinase inhibitor approved for the treatment of rheumatoid arthritis (RA). We compared the effectiveness and safety of tofacitinib, disease-modifying antirheumatic drugs (DMARDs), tumor necrosis factor inhibitors (TNFi), and non-TNF biologics in patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Machado, Marina Amaral de Ávila, Moura, Cristiano Soares de, Guerra, Steve Ferreira, Curtis, Jeffrey R., Abrahamowicz, Michal, Bernatsky, Sasha
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865387/
https://ncbi.nlm.nih.gov/pubmed/29566769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-018-1539-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados